Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects
暂无分享,去创建一个
[1] M. Bally,et al. Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes. , 2003, Vaccine.
[2] P. Wingfield,et al. Characterization of a Conformational Epitope on Hepatitis B Virus Core Antigen and Quasiequivalent Variations in Antibody Binding , 2003, Journal of Virology.
[3] A. Jegerlehner,et al. A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses. , 2002, Vaccine.
[4] J. Reimann,et al. Priming Th1 Immunity to Viral Core Particles Is Facilitated by Trace Amounts of RNA Bound to Its Arginine-Rich Domain1 , 2002, The Journal of Immunology.
[5] A. Jegerlehner,et al. Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1 , 2002, The Journal of Immunology.
[6] F. Lechner,et al. Cross‐presentation of virus‐like particles by skin‐derived CD8– dendritic cells: a dispensable role for TAP , 2002, European journal of immunology.
[7] F. Marincola,et al. Intensity of the Vaccine-Elicited Immune Response Determines Tumor Clearance , 2002, The Journal of Immunology.
[8] Y. Kawarada,et al. NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing Oligodeoxynucleotides1 , 2001, The Journal of Immunology.
[9] K. Ishii,et al. Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells1 , 2001, The Journal of Immunology.
[10] K. Ishii,et al. Sterically Stabilized Cationic Liposomes Improve the Uptake and Immunostimulatory Activity of CpG Oligonucleotides1 , 2001, The Journal of Immunology.
[11] S. Akira,et al. Toll-like receptors: critical proteins linking innate and acquired immunity , 2001, Nature Immunology.
[12] H. Wagner,et al. Toll meets bacterial CpG-DNA. , 2001, Immunity.
[13] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[14] P. Pumpens,et al. Mutilation of RNA phage Qβ virus‐like particles: from icosahedrons to rods , 2000, FEBS letters.
[15] S. Akira,et al. The role of Toll-like receptors and MyD88 in innate immune responses , 2000, Journal of endotoxin research.
[16] R. Zinkernagel,et al. In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity. , 2000, Vaccine.
[17] A. Krieg,et al. The role of CpG motifs in innate immunity. , 2000, Current opinion in immunology.
[18] G. Hartmann,et al. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Leslie,et al. The crystal structure of the human hepatitis B virus capsid. , 1999, Molecular cell.
[20] L. Hültner,et al. Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. , 1999, Journal of immunology.
[21] K. Heeg,et al. Bacterial DNA as immune cell activator. , 1998, Trends in microbiology.
[22] R. Zinkernagel,et al. Cutting Edge Commentary: Immune Responses in the Absence of Costimulation: Viruses Know the Trick , 1998, The Journal of Immunology.
[23] J. Sprent,et al. DNA as an Adjuvant: Capacity of Insect DNA and Synthetic Oligodeoxynucleotides to Augment T Cell Responses to Specific Antigen , 1998, The Journal of experimental medicine.
[24] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[25] L. Manzel,et al. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. , 1998, Journal of immunology.
[26] A. Krieg,et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. , 1998, Journal of immunology.
[27] C. Harding,et al. CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity , 1997, The Journal of experimental medicine.
[28] C. Blank,et al. CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants , 1997, European journal of immunology.
[29] D. Richman,et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants , 1997, Nature Medicine.
[30] K. Heeg,et al. Bacterial DNA causes septic shock , 1997, Nature.
[31] C. Janeway,et al. Innate immunity: impact on the adaptive immune response. , 1997, Current opinion in immunology.
[32] A. Krieg,et al. IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. , 1996, Journal of immunology.
[33] Rolf M. Zinkernagel,et al. Immunology Taught by Viruses , 1996, Science.
[34] F. Hobbs,et al. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides. , 1995, Molecular pharmacology.
[35] R. Ueda,et al. Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Zinkernagel,et al. Induction of protective cytotoxic T cells with viral proteins , 1994, European journal of immunology.
[37] R. A. Crowther,et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy , 1994, Cell.
[38] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[39] G. Trainor,et al. Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate. , 1994, Molecular pharmacology.
[40] Y. Cheng,et al. Antisense oligonucleotides as therapeutic agents--is the bullet really magical? , 1993, Science.
[41] R M Zinkernagel,et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. , 1991, Journal of virological methods.
[42] R. Medzhitov. CpG DNA: security code for host defense , 2001, Nature Immunology.
[43] H. Häcker,et al. Signal transduction pathways activated by CpG-DNA. , 2000, Current topics in microbiology and immunology.
[44] P. Pumpens,et al. RNA Phage Qβ Coat Protein as a Carrier for Foreign Epitopes , 1996 .
[45] M. Battegay. [Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates] , 1993, ALTEX.
[46] C. Janeway. Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.